Fractyl Health, Inc. Common Stock

NASDAQ:GUTS

Biotechnology

Healthcare
$4.16 -0.81%

-$0.01 today

Market cap
$55.18M
Beta
2.34
P/E (TTM)
-0.6
EPS (TTM)
-$1.42
52W Low $0.38High $2.45

Volume 0.10M

Average 2.07M

Returns on capital

Fractyl Health, Inc. Common Stock management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

-1490.3%

avg -264.9%

ROIC

-89.5%

avg -146.9%

ROA

-116.1%

avg -117.8%

Analysis

ROIC is currently the strongest return metric at -89.5% versus its period average of -146.9%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Harith Rajagopalan

Co-Founder, Chief Executive Officer & DirectorUSD 976.42K49540.56K0.75%

Jay D. Caplan BSEE

Co-Founder, Chief Product Officer & PresidentUSD 666.86K64——

Sarah S. Toomey

General Counsel & Corporate SecretaryUSD 638.65K51——

Lara Smith Weber

Chief Financial Officer & TreasurerUSD 580.99K5120.00K0.03%

Brian Luque

Head of Investor Relations & Corporate Development————

Jon Fitzgerald

Senior Vice President of Regulatory, Quality & Clinical————

Mike Zumdahl

Senior Vice President of Market Access & Commercial Strategy————

Compensation is shown in the reported currency; data updated Oct 3, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Jun 10, 2026.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

Buys

7

$187,316.02

Sells

0

$0.00

Net Transaction Value

+$187,316.02

Net buying

Most Active

BRADLEY WILLIAM

2 transactions

Transactions sorted by date, descending.

Open-market insider purchases and sales reported during the last 12 months
Type
Sep 14, 26

BRADLEY WILLIAM

Direct

Buy$39.9K
Jun 12, 26

Royan Ajay

Direct

Buy$19.6K
Jun 10, 26

BRADLEY WILLIAM

Direct

Buy$50.3K
Jun 10, 26

Sheffield Ian

Direct

Buy$25.5K
Jun 10, 26

Rajagopalan Harith

Direct

Buy$18.3K
Jun 8, 26

Smith Weber Lara

Direct

Buy$13.7K
Dec 4, 25

Rajagopalan Harith

Direct

Buy$20K

Summary

Insiders reported 7 buys worth $187,316.02 and 0 sells worth $0.00 over the last 12 months. That adds up to net buying of $187,316.02. BRADLEY WILLIAM was the most active insider with 2 transactions.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A1 analysts
RevenueN/AN/AN/A
N/A2 analysts
Net IncomeN/AN/AN/A
N/A2 analysts
EBITN/AN/AN/A
N/A2 analysts

Analysis

Analysis will appear once historical growth or forward estimates are available for this company.

Competitors

Who does Fractyl Health, Inc. Common Stock compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about GUTS's management, answered from reported figures.

Who manages GUTS?

Fractyl Health, Inc. Common Stock (GUTS) lists 7 active executives. The top listed executive is Harith Rajagopalan, Co-Founder, Chief Executive Officer & Director.

Are GUTS insiders buying or selling?

Recent insider activity shows net buying of $60.20M.